Stockscreener 앱 받기
0.1198
0.17%
-0.0002
전일 마감가:
$0.12
열려 있는:
$0.1225
하루 거래량:
1.59M
Relative Volume:
0.11
시가총액:
$9.60M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-6.41%
1개월 성능:
-78.61%
6개월 성능:
-93.86%
1년 성능:
-98.35%
1일 변동 폭
$0.1179
$0.123
1주일 범위
$0.115
$0.1531
52주 변동 폭
$0.1013
$17.17
AEON Biopharma Inc. Stock (AEON) Company Profile
명칭
AEON Biopharma Inc.
전화
(949) 354-6499
주소
5 Park Plaza, Suite 1750, Irvine
AEON을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AEON
AEON Biopharma Inc.
|
0.1198 | 9.60M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
439.84 | 113.70B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
680.29 | 75.52B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
663.27 | 39.78B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
275.13 | 35.34B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
121.98 | 29.05B | 3.30B | -501.07M | 1.03B | -2.1146 |
AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-08-18 | 개시 | H.C. Wainwright | Buy |
AEON Biopharma Inc. 주식(AEON)의 최신 뉴스
Midday Stock Roundup: FivePoint Holdings Jumps 36% - Orange County Business Journal
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Kairos, OS Therapies, AEON See Highest Weekly Spike In Retail Following Among Biotechs: Here's Why - NewsBreak
Irvine-based Aeon Biopharma Raises $20 Million - Orange County Business Journal
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Dow Jumps Over 300 Points; US Industrial Production Beats Estimates - Benzinga
Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Benzinga
AEON Biopharma Inc (AMEX: AEON) -9.93% Decline Turns Investors Away - Stocks Register
AEON Biopharma (NASDAQ:AEON) Stock Price Down 9.9% – What’s Next? - Defense World
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
AEON Stock Plummets to 52-Week Low at $0.16 Amid Market Turbulence - Investing.com
AEON’s Value Tanks As It Closes $20m Offering Amid Botox Biosimilar Aspirations - News & Insights
AEON Biopharma announces share offering - MSN
AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering - The Manila Times
AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering - Benzinga
AEON Biopharma Raises $20M in Public Offering with Dual-Warrant Structure - StockTitan
Form 424B5 AEON Biopharma, Inc. - StreetInsider.com
AEON Biopharma sets $20 million public offering pricing By Investing.com - Investing.com Nigeria
Nasdaq Surges Over 200 Points; BioLineRx Shares Plummet - Benzinga
Stock market news: Boxlight increased by 284.78% while AEON Biopharma declined by 66.75% during mid day trading - Business Upturn
S&P Jumps 1%; Regional Health Properties Shares Spike Higher - Benzinga
Why AEON Biopharma Stock Is Down 65% Today - Benzinga
US Stocks Open Higher; Dow Jumps Over 200 Points - Benzinga
Stock market today: AEON Biopharma saw gain of 255.62% while SciSparc increased by 89.77% in early trading - Business Upturn
Aeon Biopharma prices 40M units at 50c in underwritten public offering - TipRanks
AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering - The Manila Times
Why Smart Share Global Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket - Benzinga
AEON Biopharma, Inc. Announces Launch of Proposed Public Offering - The Manila Times
Feeder Cattle (GFH20) Quote - The Globe and Mail
AEON Biopharma Announces Public Offering of Common Stock and Warrants with Aegis Capital - StockTitan
Boeing Company (BA-N) QuotePress Release - The Globe and Mail
Nvidia Corp (NVDA-Q) QuotePress Release - The Globe and Mail
AEON Biopharma (NASDAQ:AEON) & Newron Pharmaceuticals (OTCMKTS:NWPHF) Financial Review - Defense World
Head to Head Survey: AEON Biopharma (AEON) & Its Peers - Defense World
AEON Biopharma (AEON) vs. Its Peers Critical Survey - Defense World
Comparing AEON Biopharma (AEON) & Its Competitors - Defense World
Entergy Corp (ETR-N) QuotePress Release - The Globe and Mail
Amkor Technology (AMKR-Q) QuotePress Release - The Globe and Mail
Carvana Company Cl A (CVNA-N) QuotePress Release - The Globe and Mail
Migraine Market Forecasted to Surge in Coming Years, 2023-2032 Analysis by DelveInsight | Amgen, Teva Pharma, Eli Lilly, Teva Pharma, Axsome Therapeutics, AEON Biopharma, Charleston Laboratories - Barchart
TSX Global Mining Index (TXGM) QuotePress Release - The Globe and Mail
OC500 2024: Tom Schoenherr - Orange County Business Journal
Blue Owl Capital Holdings LP Acquires New Stake in AEON Biopharm - GuruFocus.com
AEON Biopharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update - The Manila Times
AEON Biopharma : Reports Third Quarter 2024 Financial Results and Provides Corporate Update Form 8 K - Marketscreener.com
AEON Biopharma Advances BOTOX Biosimilar Development, Secures FDA Meeting Milestone | AEON Stock News - StockTitan
Kailera Therapeutics Appoints Scott M. Akamine as Chief Legal Officer - GlobeNewswire
Broadcom Corp (BRCM-Q) QuotePress Release - The Globe and Mail
Mondelez Intl Inc (MDLZ-Q) QuotePress Release - The Globe and Mail
Uber Technologies Inc (UBER-N) QuotePress Release - The Globe and Mail
AEON Biopharma Inc. (AEON) 재무 분석
AEON Biopharma Inc. (AEON)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.69%
4.93%
자본화:
|
볼륨(24시간):